CEL SCI Corp (CVM) stock
CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$1.28+0.09 (+7.56%)
Close on Nov 13, 2026Market cap $22.51MP/E –Yield –
Cel Sci price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Cel Sci's price to sales ratio was 220.2× on Jan 30, 2015, against 206.1× a year earlier. Over the last 3 years it ranged from 65.1× to 445.7×, with a median of 268.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2015 | Jan 30, 2015 | 220.2× | +40.3 |
| 2014 | Dec 31, 2014 | 179.9× | +65.2 |
| 2013 | Dec 31, 2013 | 114.7× | −174.9 |
| 2012 | Dec 31, 2012 | 289.6× | +224.5 |
| 2011 | Dec 30, 2011 | 65.1× | – |
See a number that looks wrong?